APA (7th ed.) Citation

Villa, D., Hoster, E., Hermine, O., Klapper, W., Szymczyk, M., Bosly, A., . . . Dreyling, M. (2022). Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma. Blood Advances, 6(18), 5285-5294. https://doi.org/10.1182/bloodadvances.2022007371

Chicago Style (17th ed.) Citation

Villa, Diego, et al. "Bendamustine or High-dose Cytarabine-based Induction with Rituximab in Transplant-eligible Mantle Cell Lymphoma." Blood Advances 6, no. 18 (2022): 5285-5294. https://doi.org/10.1182/bloodadvances.2022007371.

MLA (8th ed.) Citation

Villa, Diego, et al. "Bendamustine or High-dose Cytarabine-based Induction with Rituximab in Transplant-eligible Mantle Cell Lymphoma." Blood Advances, vol. 6, no. 18, 2022, pp. 5285-5294, https://doi.org/10.1182/bloodadvances.2022007371.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.